HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pathophysiology and animal models of schizophrenia.

Abstract
Animal models of schizophrenia are important for research aimed at developing improved pharmacotherapies. In particular, the cognitive deficits of schizophrenia remain largely refractory to current medications and there is a need for improved medications. We discuss the pathophysiology of schizophrenia and in particular the possible mechanisms underlying the cognitive deficits. We review the current animal models of schizophrenia and discuss the extent to which they meet the need for models reflecting the various domains of the symptomatology of schizophrenia, including positive symptoms, negative symptoms and cognitive symptoms.
AuthorsGavin S Dawe, Ern Huei Hwang, Chay Hoon Tan
JournalAnnals of the Academy of Medicine, Singapore (Ann Acad Med Singap) Vol. 38 Issue 5 Pg. 425-6 (May 2009) ISSN: 0304-4602 [Print] Singapore
PMID19521643 (Publication Type: Journal Article, Review)
Topics
  • Animals
  • Drug Therapy
  • Humans
  • Models, Animal
  • Schizophrenia (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: